About InMode Ltd. 
InMode Ltd.
Pharmaceuticals & Biotechnology
Inmode Ltd is an Israel-based company. It designs, develops, manufactures and commercializes energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. The Company’s proprietary technologies are used by physicians to remodel subdermal adipose, or fatty, tissue in a variety of procedures including fat reduction with simultaneous skin tightening, face and body contouring and ablative skin rejuvenation treatments. Its products target a wide array of procedures including simultaneous fat killing and skin tightening, permanent hair reduction, skin appearance and texture, among others. The Company’s products may be used on a variety of body parts, including the face, neck, abdomen, upper arms, thighs and intimate feminine regions. It owns six product platforms: BodyTite, Optimas, Votiva, Contoura, Triton and EmbraceRF. All are market and sell traditionally to plastic and facial surgeons, aesthetic surgeons and dermatologists, among others.
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 99 Schemes (24.51%)
Foreign Institutions
Held by 150 Foreign Institutions (23.54%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Moshe Mizrahy
Chairman of the Board, Chief Executive Officer
Dr. Michael Kreindel
Chief Technology Officer, Director
Dr. Michael Anghel
Independent Director
Mr. Bruce Mann
Independent Director
Dr. Hadar Ron
Independent Director
Revenue and Profits:
Net Sales:
96 Million
(Quarterly Results - Jun 2025)
Net Profit:
27 Million
Pharmaceuticals & Biotechnology
USD 1,338 Million (Small Cap)
7.00
NA
0.00%
-0.81
28.44%
2.13






